Exploring psychological experiences of fear of complications among hospitalised people with type 2 diabetes in China: a qualitative phenomenological study Authors: Yu-qin Liu, Ju Qiu, Shao-bo Li, Wei-wei He, Yun-peng Lu, Yun-jiang Cai, Meng-di Ni, Fa-rong Liu, Hong-hong Jia Published: 2026 ABSTRACT Abstract AbstractObjectiveThis study aimed to explore the lived experiences of fear of complications (FoC) among hospitalised people with type 2 diabetes (T2D) in China and to provide insights for targeted nursing interventions.DesignA phenomenological research approach was employed to conduct semistructured interviews and the Colaizzi’s seven-step analysis method was used for data analysis. This study followed the Consolidated Criteria for Reporting Qualitative Research checklist.Participants and setting15 people with T2D were purposively recruited between March and July 2025 from the endocrinology departments of two tertiary hospitals in Daqing City, Heilongjiang Province.ResultsThree themes and 11 subthemes were identified: (1) experiencing multiple negative psychological responses (distress from negative emotions, contradictory and painful psychological states, social alienation); (2) the triggers of fear are complex (adverse outcomes of similar patients, illness uncertainty, symptom burden, self-perceived burden, economic burden) and (3) employing diverse coping strategies (negative avoidance, positive self-adjustment, seeking social support).ConclusionsHealthcare professionals should pay greater attention to FoC among people with T2D. Early psychological assessment, identification of fear triggers, strengthening social support and promoting adaptive coping strategies may help reduce fear and improve quality of life.Keywords: QUALITATIVE RESEARCH; Diabetes Mellitus, Type 2; Nursing Care; Nursing research STRENGTHS AND LIMITATIONS OF THIS STUDY The study employed a qualitative research design to capture the lived experiences of fear of complications among hospitalised people with type 2 diabetes. The study employed a qualitative research design to capture the lived experiences of fear of complications among hospitalised people with type 2 diabetes. The Colaizzi’s seven-step analysis method was used to systematically analyse interview transcripts, ensuring rigorous data interpretation. The Colaizzi’s seven-step analysis method was used to systematically analyse interview transcripts, ensuring rigorous data interpretation. Participants were recruited from two hospitals in a single Chinese city, limiting geographic representativeness. Participants were recruited from two hospitals in a single Chinese city, limiting geographic representativeness. The study only included hospitalised people with type 2 diabetes, so the findings cannot be generalised to all diabetes people. The study only included hospitalised people with type 2 diabetes, so the findings cannot be generalised to all diabetes people. Due to the translation of interviews from Chinese to English, the findings may have limited cross-cultural transferability and linguistic precision. Due to the translation of interviews from Chinese to English, the findings may have limited cross-cultural transferability and linguistic precision. Introduction According to the 11th edition of the Diabetes Atlas published by the International Diabetes Federation, the worldwide prevalence of diabetes is currently estimated at 11.1% and is expected to increase to 13.0% by 2050. The number of people with diabetes worldwide is expected to reach 853 million, with approximately 148 million cases in China, the highest of any country.1 Type 2 diabetes mellitus (T2DM) accounts for the majority of these cases.2 T2DM has an insidious onset and a prolonged course, placing patients at high risk of developing severe complications that cause substantial physical damage.3 A study from China reported a prevalence of diabetes-related complications of 76.0%, with 28.9% of patients having two or more coexisting complications.4 Under the impact of multiple disease burdens, people with diabetes often experience significant psychological distress. Previous research has shown that individuals with diabetes across different cultures and nations commonly face diabetes-related psychological, social and economic burdens, with 41% reporting poor mental health status.5 Fear of complications (FoC) refers to the specific psychological state characterised by worry regarding potential complications following diabetes diagnosis.6 Fear of progression (FoP) is the earliest concept associated with FoC, and the core of fear in people with diabetes lies precisely in worries about the development of complications.7 Notably, FoC is conceptually distinct from diabetes distress and FoP. Specifically, FoC is diabetes-specific, focusing on adverse outcomes of diabetes-related complications (eg, nephropathy, retinopathy, cardiovascular events), whereas FoP encompasses broader concerns regarding general disease deterioration. Furthermore, unlike diabetes distress, which captures the broad emotional burden of diabetes management,8 FoC specifically targets future-oriented anxiety regarding the onset and progression of complications. The Health Belief Model (HBM)9 provides a valuable framework for understanding FoC, emphasising that perceived susceptibility (subjective risk assessment) and perceived severity (subjective assessment of complication consequences) shape emotional responses and self-care behaviours. Moderate fear can promote protective health behaviours, whereas excessive fear exerts inhibitory effects, significantly compromising quality of life.10,12 Previous studies indicated that nearly 40% of people with diabetes experience severe FoC, which leads to difficulties in self-management, poor blood glucose control and decreased quality of life.13,15 Therefore, a comprehensive understanding of the lived experience of FoC among people with type 2 diabetes is essential for developing patient-centred interventions to mitigate fear and improve psychological well-being. Current research on FoC in diabetes has largely focused on quantitative investigations examining its prevalence, associated factors and relationships with psychological outcomes such as anxiety, depression and diabetes distress.13 14 Several studies have also explored how FoC influences medication adherence, glycaemic control and quality of life.16 17 However, these studies primarily rely on structured questionnaires and statistical analyses, which provide limited insight into how individuals subjectively perceive, interpret and cope with the fear of potential complications in their daily lives. Although a growing body of research highlights the psychological burden associated with diabetes, qualitative evidence exploring the lived experiences of FoC among people with type 2 diabetes remains scarce. In particular, little is known about the contextual factors that trigger such fears, patients’ emotional responses to the threat of complications, or the coping strategies they adopt to manage these concerns. Therefore, this study adopts a qualitative research approach to explore in depth the experience of FoC among hospitalised people with type 2 diabetes in China, aiming to provide a scientific basis for developing targeted intervention strategies. Methods Study design This study employed a descriptive phenomenological research design to explore the lived experiences of FoC among hospitalised people with type 2 diabetes. FoC represents a complex, subjective psychological phenomenon. While quantitative instruments effectively measure fear severity, they cannot capture how patients experience, interpret, and ascribe meaning to this fear within the specific context of hospitalisation. Phenomenology was selected because it is uniquely suited to elucidate the essence of lived experiences, enabling researchers to uncover deeper insights and meaning. In this study, the first author collected data through interviews and observations. The data were analysed using the Colaizzi seven-step method,18 with consideration given to the influence of personal culture and context. This reporting of this study adhered to the Consolidated Criteria for Reporting Qualitative Research checklist (COREQ). Participants This study employed purposive sampling to ensure demographic and clinical diversity. From September to December 2024, hospitalised people with type 2 diabetes were recruited from the endocrinology departments of two tertiary hospitals in Daqing City, Heilongjiang Province, China. We purposively selected participants with diverse demographic characteristics (including age, occupation and education level) and clinical profiles (including disease duration ranging from 1 to 30 years, number of complications from 0 to 4, and treatment regimens). Eligible participants were initially identified by attending physicians during routine clinical care. Subsequently, two senior clinical nurses, each with extensive experience in diabetes care, conducted preliminary screening of potential participants. During routine clinical interactions, the research team introduced the study to patients and provided brief information to those meeting inclusion criteria. For patients expressing interest in participating, detailed study materials were provided, and written informed consent was obtained prior to enrolment. The inclusion criteria were as follows: (1) were diagnosed with type 2 diabetes; (2) age ≥18 years; (3) the score of the Fear of Complications Questionnaire is ≥30 points; (4) have no cognitive dysfunction and the ability to communicate effectively and (5) give informed consent and voluntary participation in the study. The exclusion criteria were as follows: (1) communication disorders or mental illness and (2) comorbid severe organ dysfunction. The sample size of the study was based on the criteria that the interview data were saturated and no new topics emerged. A total of 18 potential participants were invited, of whom 3 declined due to scheduling conflicts. Ultimately, 15 participants were enrolled and coded sequentially as P1 to P15. Data collection This study employed a semistructured interview method for data collection. An interview guide was developed based on the study objectives and literature review. Two individuals who were not included in the main study participated in pilot interviews prior to formal data collection. The interview guide was subsequently refined and optimised incorporating their feedback to ensure clarity and appropriateness of content. The interview guide is presented in table 1. All interviews were conducted face-to-face by the first author, who had received systematic training in qualitative research methods. Prior to data collection, participants were provided with detailed information regarding the study purpose, procedures, and confidentiality measures. Written informed consent was obtained from all participants, with assurances that their data would be anonymised using codes and used exclusively for this study. Table 1Interview questions and promptsNo.Interview questions1Are you afraid of developing complications of diabetes? What complications are you most worried about?2In what situation do you feel this fear most strongly?3How long does this fear generally persist?4How do you respond when feelings of fear emerge?5How does the fear of complications affect you?6In what ways do you believe your family, friends or healthcare providers could support you? Interview questions and prompts Interviews were conducted in a designated consultation room at the hospital, scheduled according to participants’ availability. Each interview lasted 20–40 min. Audio recordings were made with permission, and nonverbal behaviours were documented through field notes. The interviewer employed active listening, appropriate questioning, and repetition techniques to encourage in-depth expression of experiences. Data analyses The researchers transcribed the interview content within 24 hours of its completion. One researcher transcribed the audio data, while another researcher verified the accuracy of both the audio and transcribed records. The data were organised and analysed using QSR NVivo V.14.0 software, in conjunction with manual analysis. Two researchers independently coded the transcripts. Any discrepancies were resolved through group discussion with a third researcher until consensus was reached. The interview data were analysed using Colaizzi’s seven-step analysis method18: (1) transcripts were read repeatedly to ensure complete understanding; (2) significant statements were identified and extracted; (3) recurring viewpoints were formulated as codes; (4) codes were clustered to identify meaningful concepts; (5) exhaustive descriptions were developed; (6) similar concepts were abstracted into themes and (7) the thematic structure was returned to participants for validation. This study followed the COREQ checklist. Rigor To ensure the rigour of this study, four criteria were applied: credibility, dependability, confirmability and transferability. All interviewees voluntarily participated. The research team included two members with extensive clinical experience in endocrinology, which facilitated good communication between interviewers and participants prior to the interviews, allowing participants to express their genuine inner experiences. The researchers engaged in ongoing reflection throughout the study by keeping reflective journals and discussing potential biases within the team. During data analysis, researchers systematically minimised the influence of personal experiences and preconceptions to enhance confirmability. When discrepancies arose in the distilled themes, structured discussions were conducted among the research team to reach a consensus. After data analysis, the transcribed texts were returned to participants for verification, confirming the stability of the results. Results A total of 15 participants with type 2 diabetes were interviewed. The sample comprised 8 males and 7 females, with ages ranging from 38 to 72 years (M=61.8). Diabetes duration ranged from 1 to 30 years (M=17.7). Participant characteristics are presented in table 2. Three main themes and 11 subthemes emerged from the data analysis, as illustrated in figure 1. Table 2Characteristics of the participants (n=15)CharacteristicNumberGender Male8 Female7Age ≤441 45–594 ≥6010Educational level Primary school or below3 Middle school5 High school/technical school6 Bachelor or above1Marital status Married13 Divorced/widowed2Duration of diabetes ≤52 6–102 >1011Number of complications 02 14 24 ≥35Family history Yes10 No5Insulin therapy Yes12 No3Comorbidities Yes11 No4Occupation status Employment2 Unemployment4 Retirement9Residence situation Alone2 With spouse/with children13 Characteristics of the participants (n=15) Summary of themes and subthemes. FoC, fear of complications; T2DM, type 2 diabetes mellitus. Theme 1: experiencing multiple negative psychological responses Subtheme 1: distress from negative emotions On recognising the severe consequences of diabetes complications, participants often developed fear regarding future complications. Some participants (6 out of 15) reported frequent distress from negative emotions, such as anxiety and depression. P6: “I have been anxious for several months. It affects my sleep. I have trouble falling asleep, and it’s really painful.” P13: “I’m afraid of all complications. They all cause suffering. I have cataracts and need surgery, which worries me. I hope it goes well, but if it doesn’t, it could be disastrous.” P15: “I keep wondering, what’s the point of being alive? I feel like I’m suffering from depression and negativity.” Subtheme 2: contradictory and painful psychological states Type 2 diabetes is a chronic, incurable condition. Treatment outcomes often do not meet expectations, necessitating long-term self-management and dietary restrictions for patients. The majority of participants (12 out of 15) reported experiencing a conflict between the FoC and their personal dietary preferences, which triggered contradictory and painful psychological states. P12: “My blood sugar is rarely stable. After leaving the hospital, it’s very hard to control my diet. I think it’s quite contradictory. Aren’t people living for eating and drinking? For diabetics, the most delicious food is what we want to eat. But we often can’t eat it. Diabetes itself is a contradiction.” P15: “I can’t eat this, and I can’t eat that. I get angry when I see others eating. My whole life has been wasted. For nearly 30 years, I’ve spent half my life under this disease.” Subtheme 3: social alienation Some participants (5 out of 15) reported that chronic fear and anxiety, coupled with the necessity for stringent blood sugar control, significantly impacted their daily lives. These factors contributed to social dysfunction, reduced interpersonal interactions, and self-isolation, preventing them from receiving emotional support from external sources, ultimately fostering a sense of alienation. P2: “Socializing outside has become very inconvenient. When I go out, I have to carry medications. Others eat and drink, but I need to take medicine. It’s quite inconvenient. The biggest change is that I hesitate to keep in touch with old friends. Our interactions often involve drinking wine, and I no longer feel comfortable with that. Partly it’s my age, and partly it’s diabetes. It affects my ability to drink and my mood, so I don’t want to socialize.” P4: “I had a close friend who started insulin therapy at an early age. He was once reported for injecting insulin in a restaurant bathroom. People mistakenly thought he was using drugs. Over time, he developed severe complications and became bedridden. He couldn’t walk. Eventually he moved to the south, and I haven’t heard from him in five years.” Theme 2: the triggers of fear are complex Subtheme 1: adverse outcomes of similar patients People with type 2 diabetes exhibit heightened sensitivity to information related to complications. When confronted with adverse outcomes experienced by others with the same condition, they often become more concerned about their own health. All participants reported that learning about serious complications and poor outcomes in people they knew increased their FoC. P3: “During my hospitalization, I saw an elderly woman with diabetic foot ulcers. Her toes were completely necrotic, and she had to undergo amputation bit by bit. I felt that living like that was worse than death.” P12: “Developing diabetic complications to the final stage is truly tragic. I have seen cases where hands and feet were rotting, giving off an unbearable odor. No one could get close, even with a mask. At that final stage, the suffering is immense. Honestly, living feels worse than death. It would almost be better to die sooner and end the suffering.” Subtheme 2: illness uncertainty The majority of participants (10 out of 15) indicated that, due to a lack of sufficient disease-related knowledge, they were unable to determine whether complications had occurred, when they had occurred, how to control them, or what the treatment outcomes would be once the complications became severe. This sense of uncertainty exacerbated their FoC. P2: “The doctor told me that my cataract surgery couldn’t be done for another week. But I’m still not sure about the details. I don't know if it will be painful.” P4: “I measure my blood sugar at home by myself. I always suspect that my glucose meter doesn’t work well. I’m often not sure whether my condition is getting better or worse from one moment to the next.” P11: “Some people say that insulin injections have fewer side effects, while pills have more side effects. One day, an old lady said that pills don’t have as many side effects as before. I don’t know whether pills or injections are better.” Subtheme 3: symptom burden People with type 2 diabetes are at a high risk of developing complications, commonly experiencing symptoms such as deteriorating vision, palpitations, limb numbness and hypoglycaemia. All of these complications significantly impair their quality of life. The majority of participants (10 out of 15) reported feelings of fear and anxiety when faced with a heavy symptom burden, expressing concerns about the progression of complications and the potential for unfavourable outcomes. P6: “I became very thin, felt unwell, and kept drinking water. Oh my goodness, before I was hospitalized, I was getting up six or seven times a night to urinate. I was about to break down. After the tests, my urine glucose showed four plus signs. That scared me, so I went to the hospital.” P13: “I have been diagnosed with diabetic retinopathy and diabetic peripheral neuropathy. I feel numbness and tingling in my hands. I also suspect I have diabetic nephropathy. The swelling in my feet seems related to kidney problems, and I notice foamy urine too. When I feel numbness in my hands or blurred vision, I get scared.” Subtheme 4: self-perceived burden Some participants (7 out of 15) reported that the impact of the disease had limited their ability to perform daily activities, necessitating care from family members. They expressed concern that this dependence might place a burden on their children or partners, potentially creating a long-term strain on their families. P5: “I’m afraid of being a burden to them. What will the future hold? Will they be able to take care of me later?” P7: “My severe diabetic complications have greatly increased the burden on my husband and children. I want to tell my family that if I have a major cerebral hemorrhage, I don’t want to be resuscitated. I don’t want to burden them any further.” P12: “I’m extremely afraid of complications from diabetes. What I fear most is being unable to move or take care of myself. I’m also afraid of being a burden to my son.” Subtheme 5: economic burden The occurrence of multiple complications leads to increased treatment costs. The work of some participants was limited due to their condition, resulting in reduced income. Owing to differences in personal financial situations and insurance reimbursement rates, some participants (4 out of 15) reported that the economic burden intensified their FoC. P3: “When I was first diagnosed with diabetes, I felt my life was over. I lost all sense of hope. At that time, my child was still young, and I had to work to support my family.” P7: “My vision was getting worse, and the doctor recommended laser surgery. When I got to the hospital, they suggested surgery right away. Cataracts are really unavoidable. There’s little we can do to prevent them. Besides, our income is limited, less than 4000 yuan.” Theme 3: employing diverse coping strategies Subtheme 1: negative avoidance Some participants (4 out of 15) expressed a lack of confidence in the treatment outcomes, accompanied by feelings of pessimism and helplessness. They adopted a passive avoidance strategy, which contributed to the escalation of their FoC. P5: “I feel hopeless. Even when I try to think positively, it seems there is no future. It feels like it’s all predestined. At my age, what goals can I still have?” P12: “Sometimes I wish something unexpected would happen and I would just leave this world suddenly. It would be my luck. No matter what I do, it seems useless. I can’t manage my fear. All I can do is endure it.” P13: “Whenever complications are mentioned, I feel scared. Talking about them makes me uncomfortable. I can only endure it, because worrying doesn’t help.” Subtheme 2: positive self-adjustment Some participants (7 out of 15) indicated that they would employ strategies such as positive psychological adjustment, distraction, and engagement in meaningful activities to confront and overcome their FoC. They also reported trying to improve unhealthy lifestyle habits and adopt healthier behaviours to promote well-being. P2: “When I feel unwell, I go to the hospital. Birth, aging, illness, and death are natural processes. I get a check-up at a major hospital every year. At the end of October each year, I travel to Sanya for a vacation.” P4: “In 20 years, when I’m 85, I will have lived long enough. I won’t be afraid anymore. I'm starting to reflect now. If treatment is needed, I will do it. Treat actively and adjust actively. It seems there are only benefits and no drawbacks now.” P6: “I really enjoy all kinds of recreational activities, like dancing and playing ball games. I have many ball game friends and dance friends.” Subtheme 3: seeking social support The majority of participants (10 out of 15) indicated that the support and care provided by healthcare professionals, family members, and peers were essential in significantly alleviating their FoC. P4: “I owe a lot to my good friends who also have diabetes. In the beginning, I didn’t know how to measure my blood sugar. One of them gave me a blood glucose meter. He was like an expert, coming to my home every day to check my levels. The readings were really high. Then he took me to the hospital for examination. The doctors and nurses at this hospital are also very good. They are dedicated and responsible.” P5: “Nurses always encourage me when they give me injections. I feel much more at ease now.” P14: “My family is really supportive. My children are even more anxious and concerned about me than I am. I reassure them and tell them not to worry. I also discuss diabetes complications with my friends. We remind each other, and everyone tries to maintain good control.” Discussion This study employed a phenomenological approach to explore in depth the psychological experiences of FoC among hospitalised people with type 2 diabetes in China. Three core themes were identified that illuminate, through qualitative data, the specific manifestations and complex characteristics of FoC in authentic clinical contexts. FoC imposed a substantial psychological burden on people with type 2 diabetes, manifesting as anxiety, depression, ambivalence and social alienation, corroborating prior quantitative evidence of positive associations between FoC and anxiety/depression.19 20 Participants indicated that FoC serves as a critical trigger for negative psychological states, which subsequently exacerbate FoC, establishing a vicious cycle. Negative emotional states have been demonstrated to exert direct adverse effects on glycaemic control. A meta-analysis revealed that depression and diabetes distress are significantly associated with poor glycaemic control and negatively correlated with self-management behaviours.21 Therefore, early identification of FoC and timely psychological interventions22 may not only alleviate psychological distress but also disrupt the cycle linking negative emotion, behavioural withdrawal and glycaemic deterioration, thereby potentially improving glycaemic outcomes. Notably, this study further revealed a deeper layer of emotional experience, with some participants expressing a pronounced sense of social alienation. Previous research has shown that people with type 2 diabetes experience a certain degree of social alienation, which negatively affects their quality of life and overall physical and mental health.22 23 In this study, participants who experienced social alienation reported ambivalent feelings: they desired familial support yet feared discussing their condition; they feared being unable to bear pain from deteriorating complications and, more profoundly, feared burdening their family and friends. Consequently, they chose self-isolation, which progressively deepened their fear. This finding suggests that clinical interventions should address not only the fear itself but also patients’ level of social alienation, promote their social integration, enhance their confidence in disease management, and help improve their negative psychological experiences. This study identified several triggers of FoC, including adverse outcomes experienced by peers, illness uncertainty, symptom burden, self-perceived burden and economic burden. Based on the HBM,9 when participants perceived high susceptibility to complications (eg, witnessing severe outcomes in peers) and high severity (eg, recognising potential disability or mortality), their FoC levels increased correspondingly. Conversely, when participants simultaneously perceived high barriers to action (eg, economic burden, self-perceived burden), they were more likely to adopt avoidance coping strategies. Previous research23 indicated that while avoidance may offer temporary relief from negative emotions, it tended to intensify obsessive and intrusive thoughts, ultimately failing to provide effective alleviation of fear. In contrast, adopting an active self-regulation coping strategy can effectively reduce the intensity of the patient’s fear. Moreover, the majority of participants reported receiving social support from various sources, including healthcare professionals, family members and peers. Previous studies24 demonstrated that the level of social support in people with type 2 diabetes is closely linked to their psychological well-being. As a critical external resource, social support can alleviate fear, foster an optimistic acceptance of the disease and encourage active participation in treatment adherence. Therefore, it is essential to strengthen support from healthcare professionals, family members and peers to establish a multidimensional support system. This includes providing systematic psychological education; conducting long-term follow-ups (eg, home visits, telephone consultations)25; strengthening family health education; organising peer support activities26; and utilising online platforms to facilitate real-time communication and support, thereby helping patients actively cope with FoC. This study further revealed that FoC triggers and coping strategies may vary by disease duration, complication status and gender. Participants with shorter disease duration (≤5 years) predominantly reported fear stemming from illness uncertainty and insufficient disease-related knowledge. In contrast, those with longer duration or multiple complications cited symptom burden and prior adverse outcomes as primary triggers. This finding aligns with Mishel’s Uncertainty in Illness Theory,27 which posits that uncertainty arises when individuals cannot structure or categorise disease-related stimuli into a coherent cognitive framework. Early-stage patients, having not yet developed clear cognitive schemas regarding complication patterns, are consequently more susceptible to generalised fear of the unknown. Nakao et al28 found that disease duration is an independent factor influencing the expectation of worsening conditions. Patients with a shorter disease duration have not yet established a cognitive framework for understanding the disease trajectory, making them more susceptible to ambiguous anxiety. Kuniss et al14 also reported that newly diagnosed patients overestimated their 10 year risk of complications by an average of 55.1%, far exceeding the actual prevalence, suggesting that a lack of disease-related knowledge and experience is an important reason for excessive worry. Furthermore, gender differences also exhibited certain clustering characteristics in this study. Female participants more frequently expressed concerns about self-perceived burden than their male counterparts, particularly worrying about becoming a burden to their children or family members, and reported a stronger sense of FoC. Similarly, Aghamohammadi-Kalkhoran and Valizadeh29 found in a qualitative study of Iranian people with diabetes that women experienced higher levels of fear and worry regarding complications. This finding may be related to the traditional role of women as caregivers; when women themselves require care due to illness, they are more prone to feelings of guilt and self-denial, which may exacerbate their FoC levels. Therefore, when conducting psychological interventions for FoC in people with type 2 diabetes, healthcare professionals should fully consider gender differences and provide more detailed, personalised psychological care and support for female patients. Previous qualitative research on diabetes-related psychological burden has largely focused on broad concepts such as diabetes distress or FoP.30 31 Although these studies have revealed the rich nature of psychological distress in people with diabetes, they have not distinguished complication-specific fear from other types of psychological distress. The present study systematically focused on complication-specific fear and identified its unique triggers and coping characteristics, thereby providing a scientific basis for the future development of FoC-targeted interventions. Overall, this study has revealed the real experiences and complex characteristics of FoC among hospitalised people with type 2 diabetes, highlighting the significance of FoC as a prominent psychological issue in this population. Based on the above findings, the following clinical practice recommendations are proposed. First, differentiated interventions should be implemented according to disease stage. For patients in the early stage of the disease, disease education should be strengthened to help them establish a scientific understanding of complications and reduce uncertainty-driven fear. For those with a longer disease duration or already established complications, the focus should shift to symptom management, cognitive restructuring and emotion regulation to help them cope with specific threats.32 Second, attention should be paid to gender differences and self-perceived burden. For female patients with a higher level of self-perceived burden, family support systems should be strengthened, and family members should be encouraged to participate in disease management to alleviate their feelings of guilt and psychological burden.33 Third, it is recommended that FoC assessment be integrated into routine nursing care. Standardised tools should be used for routine FoC screening among hospitalised people with type 2 diabetes, and attention should be paid to their disease experiences to enable individualised interventions. Fourth, a multidimensional support system should be established. By identifying the specific needs of different patients, support from healthcare professionals, families and peers should be integrated to provide more personalised psychosocial care, thereby more effectively alleviating FoC and improving patients’ psychological health outcomes. Limitations This study has several limitations. First, all the participants came from two hospitals within the same city. Due to the hospital-based sampling method used, the experiences of patients with mild and stable conditions in the community might not be fully reflected. Second, as a qualitative study, the findings cannot establish causal relationships between variables, limiting predictive or explanatory generalisability. Third, data relied on participant recall, which may be subject to recall bias; participants may selectively remember or reinterpret past experiences based on current emotional states. Conclusions This qualitative study revealed three main themes of FoC among people with type 2 diabetes: experiencing multiple negative psychological responses, the triggers of fear being complex and employing diverse coping strategies. Integrating routine psychological assessment of FoC into diabetes care may help clinicians identify at-risk individuals and provide early, targeted psychological counselling to alleviate negative emotional experiences. Future interventions should focus on identifying patients’ specific fear triggers, establishing comprehensive support systems, and guiding patients towards adopting proactive coping strategies to reduce the negative impact of FoC and improve overall quality of life. Acknowledgements We are grateful to the people with type 2 diabetes who participated in this study for sharing their psychological experiences regarding fear of complications. Footnotes Funding: The study was financially supported by Humanities and Social Science Foundation of the Ministry of Education of China (No. 22YJAZH035). Prepublication history for this paper is available online. To view these files, please visit the journal online (https://doi.org/10.1136/bmjopen-2026-117522). Data availability free text: The datasets generated and analysed in this study are not publicly available due to the principle of confidentiality. They are available from the corresponding author on reasonable request. Patient consent for publication: Not applicable. Ethics approval: This study involves human participants and was approved by the Ethics Committee of Harbin Medical University (HMUDQ20251029002). Participants gave informed consent to participate in the study before taking part. Provenance and peer review: Not commissioned; externally peer reviewed. Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research. Data availability statement Data are available on reasonable request. References Data Availability Statement Data are available on reasonable request.